close

Agreements

Date: 2016-02-23

Type of information: Opening of new premises

Compound:

Company: Reneuron (UK)

Therapeutic area: Regenerative Medicine

Type agreement: opening of new premises

Action mechanism:

Disease:

Details: • On February 23, 2016, ReNeuron announced that, from 29 February 2016, its headquarters, research laboratories and manufacturing facilities will be located at a new purpose-built building on the Pencoed Business Park, just off the M4 motorway at Pencoed, South Wales. The fit-out of the office accommodation and laboratories at the site is complete. Work is continuing, as planned, on the fit-out and eventual validation and licensing of the manufacturing areas of the facility.

Financial terms:

Latest news:

Is general: Yes